Sex differences in elite track and field performances and inferences about steroid doping
Experimental Physiology · 2025
DOI: 10.1113/ep091916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Physiology, 2025. Verfasst von Diana B Collantes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Doping in Sports, Athletic Performance, Track and Field, Sex Characteristics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Females likely experience larger performance benefits from androgenic‐anabolic steroids than males. We set out to determine if there were temporal differences in select athletics (track and field) records between females and males. Exploratory aims included: (1) evaluating the improvements in female and male world records over time, and (2) investigating the influence of doping programs on male and female world records before and after 1990, when sports governing bodies began to implement random out‐of‐competition and systematic in‐competition drug testing. We collected the top 500 performances of all time for both sexes from an online database (worldathletics.org) in four running events (100, 200, 400 and 800 m) and two throwing events (discus throw and shot‐put). Data were stratified into quintiles based on world record ranking (1st to 100th, 101st to 200th, etc.). The temporal distribution of the top 100 female performers was significantly earlier than the top 100 male performers (year: 2000 ± 1 vs. 2005 ± 1, respectively; P < 0.0001). Within the event, the top performances occurred significantly earlier for females in the 800 m (year: 1995 ± 15 vs. 2003 ± 12; P = 0.0007) and shot‐put (year: 1992 ± 14 vs. 2003 ± 17; P = 0.0004). Among females, world records rapidly improved through the 1980s, but following 1990, the world records ceased to improve. Geographically, there was a greater representation of countries with state‐sponsored doping programs, specifically among female performances. We postulate these sex differences in the temporal distribution of top performances are likely associated with enhanced effectiveness of exogenous androgens (steroid doping) among female athletes with lower endogenous androgen hormones compared to males.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Health and Kinesiology, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
- Beckman Institute for Advanced Science and Technology, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Duke University School of Law, Durham, North Carolina, USA.
- Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, North Carolina, USA.
ORCID-Profile: Diana B Collantes, Jonathon W Senefeld, Kathryn F Larson, Michael J Joyner, Shalaya Kipp
Zitieren
APA
Collantes, D. B., Senefeld, J. W., Larson, K. F., Coleman, D. L., Joyner, M. J., & Kipp, S. (2025). Sex differences in elite track and field performances and inferences about steroid doping. Experimental Physiology. https://doi.org/10.1113/ep091916
Vancouver
Collantes DB, Senefeld JW, Larson KF, Coleman DL, Joyner MJ, Kipp S. Sex differences in elite track and field performances and inferences about steroid doping. Experimental Physiology. 2025. doi:10.1113/ep091916
BibTeX
@article{Collantes2025,
author = {Collantes, Diana B and Senefeld, Jonathon W and Larson, Kathryn F and Coleman, Doriane Lambelet and Joyner, Michael J and Kipp, Shalaya},
title = {Sex differences in elite track and field performances and inferences about steroid doping},
journal = {Experimental Physiology},
year = {2025},
doi = {10.1113/ep091916}
}
EUVIMED